IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 10 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $373,000 | +37200.0% | 65,700 | +16325.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 400 | +300.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 100 | -99.2% | 0.00% | – |
| Q3 2015 | $80,000 | +263.6% | 12,593 | +349.8% | 0.00% | – |
| Q2 2015 | $22,000 | +1000.0% | 2,800 | +845.9% | 0.00% | – |
| Q2 2014 | $2,000 | +100.0% | 296 | +0.7% | 0.00% | – |
| Q3 2013 | $1,000 | – | 294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 734,363 | $1,182,000 | 0.24% |
| MARATHON ASSET MANAGEMENT LP | 792,434 | $1,276,000 | 0.14% |
| CORRADO ADVISORS, LLC | 123,119 | $198,000 | 0.11% |
| BARD ASSOCIATES INC | 60,700 | $98,000 | 0.05% |
| Granite Investment Partners, LLC | 127,214 | $205,000 | 0.01% |
| ARDSLEY ADVISORY PARTNERS LP | 20,000 | $32,000 | 0.00% |
| Virtu Financial LLC | 15,692 | $25,000 | 0.00% |
| CITIGROUP INC | 250 | $0 | 0.00% |
| BlackRock Inc. | 71,194 | $115,000 | 0.00% |
| Bank of New York Mellon Corp | 38,816 | $62,000 | 0.00% |